Literature DB >> 15231368

Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy.

Akiyasu Baba1, Tsutomu Yoshikawa, Yukiko Fukuda, Takashi Sugiyama, Megumi Shimada, Makoto Akaishi, Kanji Tsuchimoto, Satoshi Ogawa, Michael Fu.   

Abstract

AIM: To characterise the clinical significance of M2-muscarinic acetylcholine receptor autoantibodies (M2-AAB) in patients with dilated cardiomyopathy (DCM). METHODS AND
RESULTS: Sera from 104 patients with DCM, age-matched with 104 patients with idiopathic atrial fibrillation (Af) and 104 healthy control subjects, were screened for M2-AAB by enzyme-linked immunosorbent assay (ELISA). IgG purified by Protein-A column was also used as a primary antibody in ELISA. In DCM, M2-AAB were detected in 40% of patients using whole sera and in 36% of patients using purified IgG. M2-AAB were also found in several patients with idiopathic Af (23%, 23%), and these frequencies were significantly higher than those in healthy subjects (8%, 8%). Af was more common in AAB-positive than in AAB-negative patients with DCM. Multivariable analysis confirmed that M2-AAB were independent predictors of the presence of Af in such patients. We determined electrophysiological changes by adding patient purified M2-AAB to chick embryos. Purified IgG from both Af and DCM patients exhibited negative chronotropic effects and induced supraventricular arrhythmias.
CONCLUSION: M2-AAB may play a role in mediating the development of Af in patients with DCM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231368     DOI: 10.1016/j.ehj.2004.05.012

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  32 in total

Review 1.  Autoantibodies and cardiovascular dysfunction: cause or consequence?

Authors:  Yuji Nagatomo; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2014-12

Review 2.  The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.

Authors:  Udi Nussinovitch; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 3.  Autoantibodies and cardiac arrhythmias.

Authors:  Hon-Chi Lee; Kristin T L Huang; Xiao-Li Wang; Win-Kuang Shen
Journal:  Heart Rhythm       Date:  2011-07-06       Impact factor: 6.343

4.  Development of cardiomyopathy and atrial tachyarrhythmias associated with activating autoantibodies to beta-adrenergic and muscarinic receptors.

Authors:  Xichun Yu; Eugene Patterson; Stavros Stavrakis; Shijun Huang; Isabel De Aos; Sean Hamlett; Madeleine W Cunningham; Ralph Lazarra; David C Kem
Journal:  J Am Soc Hypertens       Date:  2009-01-20

5.  Elevated M2-muscarinic and β1-adrenergic receptor autoantibody levels are associated with paroxysmal atrial fibrillation.

Authors:  Muhammed U Yalcin; Kadri M Gurses; Duygu Kocyigit; Sacit Altug Kesikli; Ahmet Hakan Ates; Banu Evranos; Hikmet Yorgun; Mehmet L Sahiner; Ergun B Kaya; Mehmet A Oto; Dicle Guc; Necla Ozer; Kudret Aytemir
Journal:  Clin Res Cardiol       Date:  2014-10-29       Impact factor: 5.460

6.  Implications of a vasodilatory human monoclonal autoantibody in postural hypotension.

Authors:  Hongliang Li; Jonathan Zuccolo; David C Kem; Caitlin Zillner; Jiyeon Lee; Kenneth Smith; Judith A James; Madeleine W Cunningham; Xichun Yu
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

7.  Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism.

Authors:  Stavros Stavrakis; Xichun Yu; Eugene Patterson; Shijun Huang; Sean R Hamlett; Laura Chalmers; Reji Pappy; Madeleine W Cunningham; Syed A Morshed; Terry F Davies; Ralph Lazzara; David C Kem
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

8.  Opposing cardiac effects of autoantibody activation of β-adrenergic and M2 muscarinic receptors in cardiac-related diseases.

Authors:  Stavros Stavrakis; David C Kem; Eugene Patterson; Pedro Lozano; Shijun Huang; Bela Szabo; Madeleine W Cunningham; Ralph Lazzara; Xichun Yu
Journal:  Int J Cardiol       Date:  2010-01-06       Impact factor: 4.164

Review 9.  Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.

Authors:  Jason M Lappé; Clara M Pelfrey; W H Wilson Tang
Journal:  J Card Fail       Date:  2008-05-27       Impact factor: 5.712

10.  Outcomes of plasma exchange for severe dilated cardiomyopathy in children.

Authors:  Keiichi Koizumi; Minako Hoshiai; Takako Toda; Nobuyuki Katsumata; Hiroaki Kise; Yohei Hasebe; Yousuke Kouno; Shigeaki Kaga; Shoji Suzuki; Kanji Sugita
Journal:  Heart Vessels       Date:  2016-04-27       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.